Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ... [Yahoo! Finance]
Pacific Biosciences of California, Inc. (PACB)
Last pacific biosciences of california, inc. earnings: 2/6 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.pacificbiosciences.com
Company Research
Source: Yahoo! Finance
Consumables Revenue: $18.5 million, increased 10% year over year. Service and Other Revenue: $4.7 million, compared to $4.1 million in the third quarter of 2023. Nongaap Gross Margin: 33%, compared to 32% in the third quarter of last year. Nongaap Operating Expenses: $62.4 million, a 31% decrease from the third quarter of 2023. Nongaap Net Loss: $46.0 million, representing 17 per share. Cash and Investments: $471 million at the end of the third quarter. Revo System Shipments: 22 systems delivered to 22 different customers. Annualized Pull Through on Revo Platform: Approximately $255,000. Headcount: 575 employees at the end of the quarter. Warning! GuruFocus has detected 7 Warning Signs with PACB. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Pacific Biosciences of California Inc ( NASDAQ:PACB ) unveiled several new products, including the Vega benchtop sequencer, which is exp
Show less
Read more
Impact Snapshot
Event Time:
PACB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PACB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PACB alerts
High impacting Pacific Biosciences of California, Inc. news events
Weekly update
A roundup of the hottest topics
PACB
News
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target lowered by analysts at Scotiabank from $7.00 to $6.00. They now have a "sector outperform" rating on the stock.MarketBeat
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.MarketBeat
- Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its price target raised by analysts at Piper Sandler from $2.00 to $2.50. They now have a "neutral" rating on the stock.MarketBeat
- Earnings Update: Pacific Biosciences of California, Inc. (NASDAQ:PACB) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts [Yahoo! Finance]Yahoo! Finance
- PacBio to Present at Upcoming Investor ConferencesGlobeNewswire
PACB
Earnings
- 11/7/24 - Beat
PACB
Sec Filings
- 11/12/24 - Form SC
- 11/12/24 - Form 8-K
- 11/12/24 - Form 10-Q
- PACB's page on the SEC website